BNTC
Benitec Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.68
+1.93%Margins
Gross margin
-14.2%
EBITDA margin
-9615.6%
EBIT margin
-9701.1%
Net margin
-8792.1%
FCF margin
-3704.1%
-26.7%
Return on equity
-26.1%
Return on assets
-29.3%
Return on invested capital
0.00x
Asset turnover
-$20.6M
Cash from operations
$5.38
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026